These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of HCC. de Lope CR; Tremosini S; Forner A; Reig M; Bruix J J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468 [TBL] [Abstract][Full Text] [Related]
4. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Choi JY Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948 [TBL] [Abstract][Full Text] [Related]
5. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia. Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951 [TBL] [Abstract][Full Text] [Related]
6. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Llovet JM; Fuster J; Bruix J; Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851 [TBL] [Abstract][Full Text] [Related]
7. Current strategy for staging and treatment: the BCLC update and future prospects. Forner A; Reig ME; de Lope CR; Bruix J Semin Liver Dis; 2010 Feb; 30(1):61-74. PubMed ID: 20175034 [TBL] [Abstract][Full Text] [Related]
8. Current treatment strategy for hepatocellular carcinoma. Ng KK; Poon RT Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455 [TBL] [Abstract][Full Text] [Related]
9. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gish RG; Finn RS; Marrero JA Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427 [TBL] [Abstract][Full Text] [Related]